This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Implementing an intelligent infrastructure of automation and intelligence, supported by expert services to ensure optimization, is an opportunity for health systems to enhance medication distribution processes, support sterilecompounding safety and efficiency, and ultimately improve pharmacy supply chain management.
Terri Albarano, MS, PharmD Director, Autonomous Pharmacy Advisory Board When patients are admitted to the hospital, they are typically focused on receiving the best care. One key area was in sterilecompounding of IVs – a big risk area – in which a dosing error could have serious consequences.
Studies have shown that one out of every ten can put patients at risk. Sterilecompounding is also one of the costliest functions in pharmacy operations. Still, many hospital pharmacies continue to struggle to improve safety and efficiency in their sterilecompounding operations. 5 at 2 p.m. EDT (11 a.m.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterilecompounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospitalpatient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion. But automation alone is not enough.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospitalpatient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion. But automation alone is not enough.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content